Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Title
Intervention Indication Therapeutic Area Year Actions
Ixazomib Citrate for Newly Diagnosed Multiple Myeloma – maintenance therapy following autologous stem cell transplant Ixazomib (Ninlaro; MLN 9708; MLN 2238; ixazomib citrate) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2018 View  |  Download
Ixazomib citrate for newly diagnosed multiple myeloma inelgible for autologous stem cell transplant– maintenance therapy Ixazomib (Ninlaro; MLN 9708; MLN 2238; ixazomib citrate) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications